NIH, National Cancer Institute, Division of Cancer Treatment and Diagnosis (DCTD) NIH - National Institutes of Health National Cancer Institute DCTD - Division of Cancer Treatment and Diagnosis

The addition of MESNA in vitro prolongs prothrombin time similar to N-acetyl cysteine.

Author(s): Blasi A, Caballo C, Galán AM, Taura P, Beltran J, Escolar G, Lozano M

Publication: Clin Chem Lab Med, 2013, Vol. 51, Page e297-9

PubMed ID: 23929884 PubMed Review Paper? No

Purpose of Paper

The purpose of this paper was to determine the effects of the adjuvant drug sodium 2-sulfanylethanesulfonate (MESNA) on prothrombin time (PT), activated partial thromboplastin time (aPTT), and thromboelastometry in spiked blood specimens.

Conclusion of Paper

When blood specimens were incubated with 1000 uM of MESNA, PT ratio increased significantly, and maximum clot firmness (MCF) decreased slightly but significantly compared to specimens incubated with saline (baseline). When blood specimens were incubated with 2000 uM of MESNA, PT ratio was significantly increased from baseline but was not significantly different from that observed in specimens incubated with 1000 uM MESNA. Interestingly, MCF was unaffected by incubation of blood with 2000 uM MESNA compared to blood incubated with saline. No significant changes were observed in aPTT, clot time (CT), clot formation time (CFT), alpha angle, or clot lysis parameters when blood was incubated with any amount of MESNA.

Studies

  1. Study Purpose

    The purpose of this study was to determine the effects of the adjuvant drug, MESNA, on PT, aPTT, and thromboelastometry in spiked blood specimens. Blood was incubated with either saline, 1000 uM of MESNA, or 2000 uM of MESNA for 1 hour at 37 degrees C prior to analysis.

    Summary of Findings:

    When blood specimens were incubated with 1000 uM of MESNA, PT ratio increased significantly (p<0.01), and MCF decreased slightly but significantly (p<0.01) compared to specimens incubated with saline (baseline). When blood specimens were incubated with 2000 uM of MESNA, PT ratio was significantly increased from baseline but was not significantly different from that observed in specimens incubated with 1000 uM MESNA. Interestingly, MCF was unaffected by incubation of blood with 2000 uM MESNA compared to blood incubated with saline. No significant changes were observed in aPTT, CT, CFT, alpha angle, or clot lysis parameters when blood was incubated with any amount of MESNA.

    Biospecimens
    Preservative Types
    • None (Fresh)
    Diagnoses:
    • Normal
    Platform:
    AnalyteTechnology Platform
    Morphology Hematology/ auto analyzer
    Cell count/volume Hematology/ auto analyzer
    Pre-analytical Factors:
    ClassificationPre-analytical FactorValue(s)
    Biospecimen Aliquots and Components Biospecimen components Saline
    1000 uM MESNA
    2000 uM MESNA

You Recently Viewed  

News and Announcements

  • New Articles on the GTEx Project are Now FREELY Available!

  • Just Published!

  • April 24, 2024: Biobanking for Precision Medicine Seminar

  • More...